Press Releases

Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments against proliferative diseases, today announces the presentation by Professor Tatjana Stankovic, from the University of Birmingham (UK) School...

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its ECLIPSE II Hepatitis C Phase I/IIa multicenter study will be presented...

CertiVox, an information security company, today announces it has received the Yearling category of the 2011 Bully Award, an honour presented by White Bull Summits to Europe’s leading technology, media and telecommunications (TMT) companies. The award...

TxCell SA, a biotechnology company developing Treg cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high unmet medical needs, announces today the presentation of final positive results of the phase I/II study in Crohn’s disease...

Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced today that Trophos organized two round-table meetings to establish the endpoints and design for...

Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the discovery of novel anti-cancer therapies, announce today that they have entered into an agreement to co-develop and co-promote pre-clinical oncology in vivo solutions for...

Rib-X Pharmaceuticals, Inc. announced that results from the Company's RX-04 development program will be featured today in the Novel Antimicrobial Agents poster session at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held...